About Contact Us Careers

Neoplasm Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3898
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Neoplasm Treatment Landscape

Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis

Bayer AG
Merck & Co., Inc.
Novartis AG
Abbott Laboratories
Exelixis, Inc.
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche
Amgen Inc.

Browse Key Market Insights with Data Illustration:

Neoplasm Treatment Market Size, Growth Forecasts 2025-2037

In the News

Exelixis Inc. announced the successful results for Cabozantinib in combination with immunotherapies in patients with advanced colorectal cancer.
Merck & Co announced the complete acquisition of Acceleron Pharma Inc., to explore the opportunities in medical research.

Author Credits: Radhika Pawar

Report ID: 3898
Published Date: Dec 20, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of neoplasm treatment is estimated at USD 241.74 billion.

The neoplasm treatment market size was over USD 206.64 billion in 2024 and is anticipated to cross USD 730.42 billion by 2037, growing at more than 10.2% CAGR during the forecast period i.e., between 2025-2037. Surging change in genetic mutations, increasing geriatric population will boost the market growth.

North America industry is anticipated to account for largest revenue share by 2037, attributed to rising cases of cancer in the region.

The major players in the market are Thermo Fisher Scientific Inc., Bayer AG, Merck & Co., Inc., Novartis AG, Abbott Laboratories, Exelixis, Inc., Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Amgen Inc.

Inquiry Before Buying Request Free Sample